Spectral characterization, electrochemical, antimicrobial and cytotoxic studies on new metal(II) complexes containing N2O4 donor hexadentate Schiff base ligand

We report the biological activity of the new Schiff base ligand H2L (H2L = 6,6′-((1E,11E)-5,8-dioxa-2,11-diazadodeca-1,11-diene-1,12-diyl)bis(2,4-dichlorophenol)), its derived metal(II) complexes [Cu(L)] (1), [Co(L)] (2), [Ni(L)] (3) and [Zn(L)] (4), along with their structural characterizations by using various analytical and spectroscopic techniques. Electrochemical investigations showed that all of these Cu(II), Co(II) and Ni(II) complexes were reversibly reducible. Although the change of the number of unpaired electrons are different of the metal cations, they have an effect on the redox potentials of the Co(II)/(I), Ni(II)/(I) and Cu(II)/(I) couples. The 1H NMR and FTIR data concluded that the Schiff base ligand H2L acts as a hexadentate ligand coordinating with metal(II) ions through the oxygen atoms of the (COC), phenolic (COH) groups and nitrogen atom of the azomethine (CHN) group. UV-Visible absorption spectra studies clearly revealed the octahedral geometry of the prepared metal(II) complexes. Complexes 1 and 4 were found to be efficient in bringing about antimicrobial activities. The proposed mechanism of their antimicrobial activities has been discussed. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay showed the remarkable cytotoxicity of complex 1 (IC50 = 17 ± 1.3 μg/mL) on human breast cancer MCF-7 cells than Schiff base ligand H2L and complexes 2–4. Moreover, AO/EB staining assay revealed cell death due to apoptosis in MCF-7 cells and the generation of ROS by the Schiff base ligand H2L and its derived metal(II) complexes 1–4 may be a possible cause for their cytotoxic activity.